Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $238.00 | Total: $1,190.00 |
| 1 | 10 | $201.60 | Total: $2,016.00 |
| 1 | 25 | $170.80 | Total: $4,270.00 |
| 1 | 50 | $145.60 | Total: $7,280.00 |
| 1 | 100 | $126.00 | Total: $12,600.01 |
Overview
OPC-28326 is a specific an ?2-adrenergic receptor antagonist and acts as a peripheral vasodilator. OPC-28326 inhibits ?2A-, ?2B- and ?2C-adrenoceptors with Ki of 2040, 285, and 55?nM, respectively.
Chemical Properties
| Molecular Formula | C26H35N3O2 |
| Molecular Weight | 421.58 |
| CAS Numbers | 167626-17-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(=O)(C1=CC(C)=C(NC(CC)=O)C(C)=C1)N2CCC(N(CCC3=CC=CC=C3)C)CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Sumi M, et al. OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis. Biomed Pharmacother. 2007 May;61[4] 209-15. Epub 2006 Dec 28.